tiprankstipranks
Trending News
More News >
Option Care Health (OPCH)
NASDAQ:OPCH
US Market

Option Care Health (OPCH) Earnings Dates, Call Summary & Reports

Compare
459 Followers

Earnings Data

Report Date
Jul 30, 2025
Before Open (Confirmed)
Period Ending
2025 (Q2)
Consensus EPS Forecast
0.38
Last Year’s EPS
0.3
Same Quarter Last Year
Based on 8 Analysts Ratings

Earnings Call Summary

Q1 2025
Earnings Call Date:Apr 29, 2025|
% Change Since: 5.83%|
Earnings Call Sentiment|Positive
Option Care Health reported strong first-quarter results with significant revenue and adjusted EBITDA growth. Strategic investments and successful integration of acquisitions highlight operational progress. While there are concerns regarding the economic impact of STELARA and potential tariffs, the company's positive guidance and strategic initiatives provide a stable outlook.
Company Guidance -
Q2 2025
During the first quarter of 2025, Option Care Health demonstrated significant growth and strategic advancements, as highlighted in their earnings conference call. The company achieved a 16% increase in revenue compared to the previous year, driven by mid-teens growth in acute therapies and high-teens growth in chronic therapies. This performance contributed to a 13.7% year-over-year increase in adjusted EBITDA, reaching $111.8 million. The company also expanded its capabilities by opening a new compounding pharmacy, additional infusion clinics, and investing in technology and nursing resources. Despite potential economic uncertainties, such as proposed tariffs, Option Care Health increased the lower end of their full-year adjusted EBITDA guidance range, projecting revenues between $5.4 billion and $5.6 billion and adjusted EBITDA between $455 million and $470 million. The company also reported a strong balance sheet, enabling strategic investments, including the acquisition of Intramed Plus and a $100 million stock repurchase.
Strong Revenue Growth
Option Care Health reported a 16% increase in revenue over the first quarter of last year, with mid-teens growth in acute therapies and high teens growth in chronic therapies.
Adjusted EBITDA Growth
The company achieved a 13.7% growth in adjusted EBITDA year-over-year, reflecting disciplined spending and strong top-line performance.
Strategic Investments
Investments included opening a new compounding pharmacy, three infusion clinics, enhancing technology, and expanding nursing capabilities.
Intramed Plus Acquisition Integration Success
The acquisition of Intramed Plus is on track to meet financial and operational goals, expanding care models and infusion clinic footprint.
Advanced Technology Implementation
The company expanded the use of robotic process automation and machine learning, improving revenue cycle management and cash collection velocity.
Positive Outlook and Guidance
For 2025, the company expects to generate revenue of $5.4 billion to $5.6 billion and adjusted EBITDA of $455 million to $470 million.
Share Repurchase Program
Repurchased $100 million of stock during the quarter, reflecting confidence in the company's financial health and future prospects.

Option Care Health (OPCH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

OPCH Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 30, 2025
2025 (Q2)
0.38 / -
0.3
Apr 29, 2025
2025 (Q1)
0.34 / 0.40
0.2653.85% (+0.14)
Feb 26, 2025
2024 (Q4)
0.36 / 0.44
0.3237.50% (+0.12)
Oct 30, 2024
2024 (Q3)
0.31 / 0.41
0.3132.26% (+0.10)
Jul 31, 2024
2024 (Q2)
0.28 / 0.30
0.63-52.38% (-0.33)
Apr 23, 2024
2024 (Q1)
0.23 / 0.26
0.2123.81% (+0.05)
Feb 22, 2024
2023 (Q4)
0.29 / 0.32
0.2623.08% (+0.06)
Oct 25, 2023
2023 (Q3)
0.29 / 0.31
0.2147.62% (+0.10)
Jul 27, 2023
2023 (Q2)
0.23 / 0.63
0.19231.58% (+0.44)
May 03, 2023
2023 (Q1)
0.18 / 0.21
0.1723.53% (+0.04)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

OPCH Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 29, 2025
$32.97$30.69-6.92%
Feb 26, 2025
$32.63$33.15+1.59%
Oct 30, 2024
$30.50$23.55-22.79%
Jul 31, 2024
$31.35$29.69-5.30%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Option Care Health (OPCH) report earnings?
Option Care Health (OPCH) is schdueled to report earning on Jul 30, 2025, Before Open (Confirmed).
    What is Option Care Health (OPCH) earnings time?
    Option Care Health (OPCH) earnings time is at Jul 30, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is OPCH EPS forecast?
          OPCH EPS forecast for the fiscal quarter 2025 (Q2) is 0.38.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis